Erythromycin ethylsuccinate; sulfisoxazole acetyl - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for erythromycin ethylsuccinate; sulfisoxazole acetyl and what is the scope of patent protection?
Erythromycin ethylsuccinate; sulfisoxazole acetyl
is the generic ingredient in three branded drugs marketed by Barr, Alra, and Ross Labs, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.Summary for erythromycin ethylsuccinate; sulfisoxazole acetyl
| US Patents: | 0 |
| Tradenames: | 3 |
| Applicants: | 3 |
| NDAs: | 3 |
| DailyMed Link: | erythromycin ethylsuccinate; sulfisoxazole acetyl at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for erythromycin ethylsuccinate; sulfisoxazole acetyl
US Patents and Regulatory Information for erythromycin ethylsuccinate; sulfisoxazole acetyl
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Barr | ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL | erythromycin ethylsuccinate; sulfisoxazole acetyl | GRANULE;ORAL | 062759-001 | May 20, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ross Labs | PEDIAZOLE | erythromycin ethylsuccinate; sulfisoxazole acetyl | GRANULE;ORAL | 050529-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alra | ERYZOLE | erythromycin ethylsuccinate; sulfisoxazole acetyl | GRANULE;ORAL | 062758-001 | Jun 15, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
